Swiss partners

Backbone of the Swiss Financial Center

SIX Swiss Exchange, based in Zurich, is one of the most technologically advanced stock exchanges in the world. SIX develops and operates superior and innovative infrastructure services for the Swiss financial center and Swiss banks. This includes services in the securities business, for payment transactions, for financial information, and for cyber security. SIX connects financial market participants in Switzerland and throughout the world. The company is owned by around 120 national and international financial institutions that are active in the Swiss financial center.

History

SIX has stood for innovation and stability on the global financial markets since 2008. Its strength is founded on its history: SIX was formed from the merger of experienced financial companies – with their beginnings going back to around 1930.

SIX in Figures

• 13 bn CHF was the operating income of SIX in 2019
• 5 mn CHF was the Group net profit of SIX in 2019
• 2,710 employees in 20 countries work at SIX
• 85,6% are the market share of trading in SLI stocks (2019 average)
• 658mn interbank clearing transactions were settled by SIX in 2019.
• 7 mn financial instruments are in the database of SIX Financial Information

Integral Structures Ensure Strategic Success

The integral structures of SIX are one of the strategic drivers of success. Although each business unit sets its own strategic goals in its respective area of responsibility, innovative and value adding solutions are developed particularly when these business units connect and collaborate. Thus, the Innovation & Digital business unit acts as a facilitator dealing with technologies and developments relevant for the future and bringing together all the activities undertaken by SIX in this area.

Industry Trends

Leading Life Sciences Exchange in Europe

SIX Swiss Exchange offers Swiss and foreign Life Sciences companies ideal conditions for raising capital. As a proactive partner, SIX Swiss Exchange facilitates an efficient listing and access to financially powerful Swiss and international investors and high liquidity.

Switzerland has the world’s highest per capita density of bio and medtech companies. This is the result of a long-standing and fruitful interactive relationship between the well-established Swiss pharma, biotech and medtech industries and the country’s financial institutions.

SIX Swiss Exchange is Europe’s leading exchange for Life Sciences companies, representing more than one third of the European Life Sciences market capitalization across Europe’s major stock exchanges. Switzerland’s capital-rich investor base, strong banking system and its leading industry know-how make up the country’s vibrant Life Sciences ecosystem. This enables companies to efficiently raise capital with the view to drive scientific discovery through to market launch.

SIX in China

On July 28, 2022, GEM, Gotion High-tech, Keda Industrial Group and Ningbo Shanshan became the first Chinese companies to list GDRs on SIX Swiss Exchange. The listings are part of the newly launched China-Switzerland Stock Connect program. Find out more

From left to right: Thomas Zeeb, Global Head Exchanges, SIX; Daniela Stoffel, Swiss State Secretary; Wang Shihting, Chinese Ambassador to Switzerland

In October 2019, SIX and Shenzhen Stock Exchange (SZSE) signed a Memorandum of Understanding (MoU) to start an initiative with the aim of connecting the investors’ community and companies in both countries to allow for the establishment of capital formation possibilities on a larger scale. Find out more

In April 2019, SIX and Shanghai Stock Exchange renewed their Memorandum of Understanding (MoU) with the intention to further deepen their collaboration which was initiated in 2015. A Swiss delegation visited the Shanghai Stock Exchange, where the two parties signed the document in the presence of Swiss Confederation President Ueli Maurer. Find out more

In 1998, the Swiss Biotech Association (SBA) represents the interests of the Swiss biotech industry. To support its members in a competitive market, the Swiss Biotech Association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources. To strengthen and promote the Swiss biotech industry, the Swiss Biotech Association collaborates with numerous partners and life science clusters globally under the brand Swiss Biotech™.

For more information about SBA, we invite you to visit their website: 

https://www.swissbiotech.org/association/

Founded in 2004 by the canton of Vaud public authorities, Biopôle SA is a private, not-for-profit organisation, which owns, manages and promotes the life sciences campus. We believe that interpersonal and inter-company relationships are the key to successful innovation. That’s why we focus on creating an environment in which you and your teams can prosper by collaborating with the Biopôle community and beyond.

For more information about Biopôle, we invite you to visist their website: 

https://www.biopole.ch